Genetic tracking could predict which leukemia patients will stay Cancer-Free
NCT ID NCT02756962
Summary
This study is testing whether measuring leftover cancer mutations after initial treatment can better predict which acute myeloid leukemia patients will relapse. Researchers are tracking 107 adults who have achieved remission to see if patients who clear these mutations have better survival than expected. The goal is to improve risk assessment so doctors can better decide who needs more aggressive treatment like stem cell transplants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
-
University of Rochester
Rochester, New York, 14642, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.